1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on August 8, 2025

AMGN

MT Newswires

a day ago

HSBC Adjusts Amgen Price Target to $343 From $337, Maintains Buy Rating

Amgen (AMGN) Completes US$60,594 Million Share Buyback After 14 Years
AMGN

Simply Wall St.

2 days ago

Amgen (AMGN) Completes US$60,594 Million Share Buyback After 14 Years

Why S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise Quarter
AMGN

Investor's Business Daily

2 days ago

Why S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise Quarter

NRG Energy, Amgen, Arista Networks: Trending Tickers
AMGN

Yahoo Finance Video

2 days ago

NRG Energy, Amgen, Arista Networks: Trending Tickers

Amgen Stock Sinks As Market Eyes MariTide's Next Move
AMGN

Benzinga

2 days ago

Amgen Stock Sinks As Market Eyes MariTide's Next Move

Teva’s Ajovy becomes first migraine prevention drug approved for children
AMGN

Pharmaceutical Technology

2 days ago

Teva’s Ajovy becomes first migraine prevention drug approved for children

AMGN

MT Newswires

2 days ago

UBS Cuts Price Target on Amgen to $317 From $326, Maintains Neutral Rating

Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly
AMGN

Zacks

2 days ago

Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly

AMGN

MT Newswires

2 days ago

Goldman Sachs Adjusts Amgen Price Target to $405 From $400, Maintains Buy Rating

AMGN

MT Newswires

2 days ago

Citigroup Adjusts Price Target on Amgen to $310 From $305, Maintains Neutral Rating

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
AMGN

CNW Group

2 days ago

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

AMGN

MT Newswires

2 days ago

Morgan Stanley Lifts Price Target on Amgen to $333 From $330, Keeps Equalweight Rating

Stocks to Watch Wednesday: Disney, AMD, Super Micro, Rivian
AMGN

The Wall Street Journal

2 days ago

Stocks to Watch Wednesday: Disney, AMD, Super Micro, Rivian

AMGN

MT Newswires

2 days ago

RBC Lifts Price Target on Amgen to $330 From $320, Keeps Outperform Rating

OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee
AMGN

GlobeNewswire

2 days ago

OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee

Amgen Inc (AMGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Robust Pipeline ...
AMGN

GuruFocus.com

2 days ago

Amgen Inc (AMGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Robust Pipeline ...

Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue
AMGN

StockStory

3 days ago

Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue

Former Amgen SVP of Global Research and Renowned Cell Biologist Ray Deshaies Named to Iambic’s Scientific Advisory Board
AMGN

Business Wire

3 days ago

Former Amgen SVP of Global Research and Renowned Cell Biologist Ray Deshaies Named to Iambic’s Scientific Advisory Board

Stocks Rise Pre-Bell Ahead of Latest Corporate Earnings; Investors Monitor Tariff Developments
AMGN

MT Newswires

3 days ago

Stocks Rise Pre-Bell Ahead of Latest Corporate Earnings; Investors Monitor Tariff Developments

Global Markets Rise on Fed Rate-Cut Hopes
AMGN

The Wall Street Journal

3 days ago

Global Markets Rise on Fed Rate-Cut Hopes

Cystinosis Global Market Research Report 2025-2035 | Orphan Drug Incentives, Innovative Cysteamine Delivery, Gene Therapy Potential, and Early Diagnosis Fueling Advancements
AMGN

GlobeNewswire

3 days ago

Cystinosis Global Market Research Report 2025-2035 | Orphan Drug Incentives, Innovative Cysteamine Delivery, Gene Therapy Potential, and Early Diagnosis Fueling Advancements

Calcinosis Cutis Market Research Report 2025-2035 | Market Shifts Toward Targeted Therapies as Advances in Calcium Metabolism Research Drive Development of More Effective Treatments
AMGN

GlobeNewswire

3 days ago

Calcinosis Cutis Market Research Report 2025-2035 | Market Shifts Toward Targeted Therapies as Advances in Calcium Metabolism Research Drive Development of More Effective Treatments

AMD & Pfizer earnings, ISM services data: What to Watch
AMGN

Yahoo Finance Video

4 days ago

AMD & Pfizer earnings, ISM services data: What to Watch

Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?
AMGN

Zacks

4 days ago

Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
AMGN

Zacks

4 days ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

AMGN

MT Newswires

4 days ago

Central Bank Outlook Lifts Wall Street Pre-Bell; Asia, Europe Up

AMGN

Argus Research

4 days ago

Market Digest: TEVA, AMT, HOG, IEX, LMT, SPGI, PWR, XYL, LEA

Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps
AMGN

Bloomberg

4 days ago

Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps

Do Wall Street Analysts Like Amgen Stock?
AMGN

Barchart

4 days ago

Do Wall Street Analysts Like Amgen Stock?

Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow
AMGN

StockStory

5 days ago

Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow

What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald’s and More
AMGN

Investopedia

5 days ago

What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald’s and More

Amgen (AMGN) Board Declares US$2.38 Dividend for Q3 2025
AMGN

Simply Wall St.

6 days ago

Amgen (AMGN) Board Declares US$2.38 Dividend for Q3 2025

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week
AMGN

The Wall Street Journal

7 days ago

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND
AMGN

PR Newswire

7 days ago

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

What Trump's Big Pharma CEO letters mean for drug pricing power
AMGN

Yahoo Finance Video

8 days ago

What Trump's Big Pharma CEO letters mean for drug pricing power

AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS
AMGN

PR Newswire

8 days ago

AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors
AMGN

Business Wire

8 days ago

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors

Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs
AMGN

The Wall Street Journal

8 days ago

Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs

AMGN

Investing.com

8 days ago

Trump demands pharma CEOs lower drug prices within 60 days

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
AMGN

Zacks

8 days ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key Metrics
AMGN

Zacks

8 days ago

Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key Metrics

With 81% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns
AMGN

Simply Wall St.

8 days ago

With 81% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns

Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial
AMGN

Benzinga

8 days ago

Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
AMGN

GlobeNewswire

8 days ago

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas

Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health
AMGN

GlobeNewswire

8 days ago

Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health

Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market Report 2025: Global Trends, Revenue, and Market Dynamics
AMGN

GlobeNewswire

8 days ago

Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market Report 2025: Global Trends, Revenue, and Market Dynamics

UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating
AMGN

Insider Monkey

9 days ago

UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating

Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.
AMGN

Barrons.com

9 days ago

Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.

Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for
AMGN

Zacks

9 days ago

Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
AMGN

Zacks

9 days ago

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Bispecific Antibodies Market Report 2025- 2035, with Profiles of Akeso Biopharma, Alexion, Amgen, Genmab, Immunocore, Linton Pharm, Merck, OncXerna Therapeutics, Zymeworks, and More
AMGN

GlobeNewswire

10 days ago

Bispecific Antibodies Market Report 2025- 2035, with Profiles of Akeso Biopharma, Alexion, Amgen, Genmab, Immunocore, Linton Pharm, Merck, OncXerna Therapeutics, Zymeworks, and More

Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
AMGN

Zacks

10 days ago

Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth

Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
AMGN

Zacks

10 days ago

Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
AMGN

Zacks

10 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know
AMGN

Zacks

11 days ago

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know

AMGN

Investing.com

11 days ago

Biotech stocks dip as Trump administration mulls patent fee overhaul

2 Top Dividend Stocks to Buy Right Now and Hold Forever
AMGN

Motley Fool

11 days ago

2 Top Dividend Stocks to Buy Right Now and Hold Forever

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
AMGN

Zacks

11 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
AMGN

Zacks

11 days ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

BofA Reiterates a Sell Rating on Amgen (AMGN)
AMGN

Insider Monkey

12 days ago

BofA Reiterates a Sell Rating on Amgen (AMGN)

BMO Cuts Amgen (AMGN) Price Target After Mixed MariTide Data at ADA Conference
AMGN

Insider Monkey

12 days ago

BMO Cuts Amgen (AMGN) Price Target After Mixed MariTide Data at ADA Conference

Dogs of the Dow: Why Amgen’s (AMGN) Dividend Power Makes it a Standout Pick
AMGN

Insider Monkey

12 days ago

Dogs of the Dow: Why Amgen’s (AMGN) Dividend Power Makes it a Standout Pick

Is Amgen Inc. (NASDAQ:AMGN) Trading At A 50% Discount?
AMGN

Simply Wall St.

12 days ago

Is Amgen Inc. (NASDAQ:AMGN) Trading At A 50% Discount?

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment
AMGN

Insider Monkey

15 days ago

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
AMGN

Benzinga

15 days ago

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

Biosimilars Markets Global Forecast Report 2025-2035 | Launch of Glp-1 Biosimilars, Increasing Strategic Partnerships and Collaborations, & Growing Focus on Advanced R&D Fueling Opportunities
AMGN

GlobeNewswire

15 days ago

Biosimilars Markets Global Forecast Report 2025-2035 | Launch of Glp-1 Biosimilars, Increasing Strategic Partnerships and Collaborations, & Growing Focus on Advanced R&D Fueling Opportunities

Looking Beyond Yield for the Safest Dividend Payers
AMGN

Barrons.com

15 days ago

Looking Beyond Yield for the Safest Dividend Payers

2 Reasons to Like AMGN and 1 to Stay Skeptical
AMGN

StockStory

16 days ago

2 Reasons to Like AMGN and 1 to Stay Skeptical

Rheumatoid Arthritis Therapeutics Market Forecast Report 2025-2034 | Rising Preference for Combination Therapies, and Entry of Generic Drugs Supports Expansion
AMGN

GlobeNewswire

16 days ago

Rheumatoid Arthritis Therapeutics Market Forecast Report 2025-2034 | Rising Preference for Combination Therapies, and Entry of Generic Drugs Supports Expansion

Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
AMGN

Zacks

16 days ago

Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?

Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns
AMGN

Simply Wall St.

16 days ago

Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns

Do You Believe in the Growth Potential of Amgen (AMGN)?
AMGN

Insider Monkey

16 days ago

Do You Believe in the Growth Potential of Amgen (AMGN)?

Calciphylaxis Market Forecast Report 2025-2034 | Rising Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) Fueling Demand and Growth
AMGN

GlobeNewswire

16 days ago

Calciphylaxis Market Forecast Report 2025-2034 | Rising Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) Fueling Demand and Growth

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
AMGN

Zacks

17 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

AMGN

MT Newswires

17 days ago

Citigroup Adjusts Price Target on Amgen to $305 From $300, Maintains Neutral Rating

Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights
AMGN

GlobeNewswire

17 days ago

Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights

AMGN

MT Newswires

18 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

AMGN

MT Newswires

18 days ago

Sector Update: Health Care

AMGN

MT Newswires

18 days ago

Amgen Likely to Report Solid Q2, UBS Says

EdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate Product Innovation and Client Partnerships
AMGN

Business Wire

18 days ago

EdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate Product Innovation and Client Partnerships

AMGN

MT Newswires

18 days ago

UBS Adjusts Amgen Price Target to $326 From $315, Maintains Neutral Rating

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
AMGN

GlobeNewswire

18 days ago

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer

Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025
AMGN

Insider Monkey

21 days ago

Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025

Amgen (AMGN) Declines More Than Market: Some Information for Investors
AMGN

Zacks

21 days ago

Amgen (AMGN) Declines More Than Market: Some Information for Investors

HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating
AMGN

Insider Monkey

21 days ago

HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating

EBay Stock: How To Find & Own America's Greatest Opportunities
AMGN

Investor's Business Daily

21 days ago

EBay Stock: How To Find & Own America's Greatest Opportunities

Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?
AMGN

Zacks

22 days ago

Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?

Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
AMGN

Zacks

22 days ago

Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?

Thyroid Gland Disorders Diagnostics and Treatment Market Analysis Report 2024-2030 | Incorporation of AI and Advanced Therapeutics Fueling Opportunities
AMGN

GlobeNewswire

22 days ago

Thyroid Gland Disorders Diagnostics and Treatment Market Analysis Report 2024-2030 | Incorporation of AI and Advanced Therapeutics Fueling Opportunities

Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest
AMGN

StockStory

23 days ago

Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest

We Think Amgen (NASDAQ:AMGN) Can Stay On Top Of Its Debt
AMGN

Simply Wall St.

23 days ago

We Think Amgen (NASDAQ:AMGN) Can Stay On Top Of Its Debt

Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.
AMGN

Barrons.com

23 days ago

Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.

Earnings Preview: What to Expect From Amgen’s Report
AMGN

Barchart

23 days ago

Earnings Preview: What to Expect From Amgen’s Report

What Makes Amgen (AMGN) a New Buy Stock
AMGN

Zacks

24 days ago

What Makes Amgen (AMGN) a New Buy Stock

Are Medical Stocks Lagging Amgen (AMGN) This Year?
AMGN

Zacks

24 days ago

Are Medical Stocks Lagging Amgen (AMGN) This Year?

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
AMGN

Zacks

24 days ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

How To Buy Stocks Using Technical Analysis Of Past Winners To Spot Emerging Growth Stocks
AMGN

Investor's Business Daily

24 days ago

How To Buy Stocks Using Technical Analysis Of Past Winners To Spot Emerging Growth Stocks

Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?
AMGN

Zacks

24 days ago

Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?

Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More
AMGN

GlobeNewswire

24 days ago

Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
AMGN

GlobeNewswire

24 days ago

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Share on Social Networks: